Targeting Beta Cell Dysfunction With Verapamil in Longstanding T1D
Status:
Completed
Trial end date:
2021-12-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether verapamil can transiently improve beta cell
function in those who do or do not secrete proinsulin and little/no C-peptide.